Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaElise A. Olsen, Jean Nichols, Madeleine Duvic et al.|Journal of Clinical Oncology|2001Cited by 610
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia Scarisbrick, Henry K. Wong, Francine M. Foss et al.|Journal of Clinical Oncology|2015Cited by 419
Genomic landscape of cutaneous T cell lymphomaJaehyuk Choi, Richard P. Lifton, Gerald Goh et al.|Nature Genetics|2015Cited by 418
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A. Olsen, Julia Scarisbrick, Sean Whittaker et al.|Blood|2021Cited by 170
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Massimo Federico, Chadi Nabhan et al.|Current Hematologic Malignancy Reports|2015Cited by 13